X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3537) 3537
Publication (233) 233
Newsletter (170) 170
Book Review (129) 129
Book Chapter (47) 47
Book / eBook (12) 12
Conference Proceeding (9) 9
Streaming Video (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3038) 3038
female (2050) 2050
antiphospholipid syndrome (1686) 1686
adult (1302) 1302
index medicus (1239) 1239
antiphospholipid syndrome - drug therapy (1155) 1155
antiphospholipid syndrome - complications (1153) 1153
male (1023) 1023
pregnancy (962) 962
rheumatology (922) 922
antiphospholipid antibodies (895) 895
anticoagulants - therapeutic use (790) 790
thrombosis (777) 777
middle aged (756) 756
systemic lupus erythematosus (645) 645
anticardiolipin antibodies (613) 613
antiphospholipid syndrome - diagnosis (607) 607
risk factors (556) 556
antibodies (522) 522
antiphospholipid syndrome - immunology (476) 476
systemic-lupus-erythematosus (466) 466
treatment outcome (457) 457
lupus erythematosus, systemic - complications (439) 439
lupus (438) 438
anticoagulants (371) 371
hematology (369) 369
antibodies, antiphospholipid - blood (358) 358
medicine, general & internal (334) 334
lupus erythematosus, systemic - drug therapy (333) 333
adolescent (306) 306
lupus anticoagulant (300) 300
thrombosis - etiology (293) 293
aged (291) 291
aspirin - therapeutic use (280) 280
disease (280) 280
immunology (275) 275
antiphospholipid syndrome - blood (268) 268
research (266) 266
care and treatment (251) 251
drug therapy, combination (245) 245
diagnosis (239) 239
pregnancy outcome (239) 239
peripheral vascular disease (235) 235
anticoagulants - administration & dosage (224) 224
immunosuppressive agents - therapeutic use (223) 223
risk-factors (218) 218
antibodies, antiphospholipid - immunology (215) 215
warfarin - therapeutic use (215) 215
pregnancy complications - drug therapy (211) 211
aspirin (205) 205
women (203) 203
animals (202) 202
retrospective studies (201) 201
systemic lupus-erythematosus (200) 200
autoimmune diseases (197) 197
drug therapy (194) 194
young adult (194) 194
heparin - therapeutic use (193) 193
recurrence (192) 192
prevalence (191) 191
child (188) 188
medical research (188) 188
thrombosis - drug therapy (186) 186
classification criteria (185) 185
diagnosis, differential (181) 181
heparin (180) 180
follow-up studies (179) 179
medicine & public health (179) 179
therapy (177) 177
international consensus statement (176) 176
autoantibodies (174) 174
health aspects (174) 174
antiphospholipid syndrome - therapy (171) 171
medicine, experimental (171) 171
thrombosis - prevention & control (171) 171
lupus erythematosus, systemic - immunology (169) 169
antibodies, anticardiolipin - blood (168) 168
immunoglobulins (166) 166
warfarin (165) 165
prognosis (162) 162
risk (161) 161
classification (159) 159
molecular-weight heparin (155) 155
lupus erythematosus, systemic - diagnosis (152) 152
management (151) 151
antiphospholipid syndrome - physiopathology (150) 150
prevention (150) 150
anticoagulant (147) 147
lupus coagulation inhibitor - blood (146) 146
venous thromboembolism (146) 146
fibrinolytic agents - therapeutic use (145) 145
thromboembolism (145) 145
obstetrics & gynecology (141) 141
anticoagulants - adverse effects (139) 139
antiphospholipid syndrome - etiology (133) 133
autoimmunity (132) 132
thrombophilia - drug therapy (132) 132
time factors (130) 130
criteria (129) 129
heparin, low-molecular-weight - therapeutic use (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3422) 3422
French (101) 101
Spanish (58) 58
Japanese (47) 47
German (45) 45
Polish (31) 31
Russian (25) 25
Italian (10) 10
Hungarian (6) 6
Romanian (4) 4
Bulgarian (3) 3
Croatian (3) 3
Danish (3) 3
Finnish (2) 2
Hebrew (2) 2
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 03/2017, Volume 76, Issue 3, pp. 476 - 485
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 02/2010, Volume 8, Issue 2, pp. 237 - 242
See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary.  Background: The characteristics and the clinical course of antiphospholipid... 
anticoagulants | diagnosis | thrombosis | lupus anticoagulant | phospholipids | Anticoagulants | Phospholipids | Diagnosis | Thrombosis | Lupus anticoagulant | ANTICARDIOLIPIN ANTIBODIES | IGG ANTIBODIES | RECURRENT THROMBOSIS | WARFARIN THERAPY | INTERNATIONAL CONSENSUS STATEMENT | VENOUS THROMBOEMBOLISM | ANTITHROMBOTIC THERAPY | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CLASSIFICATION CRITERIA | ANTIBODY-SYNDROME | Antiphospholipid Syndrome - mortality | Lupus Coagulation Inhibitor - blood | Predictive Value of Tests | Recurrence | Venous Thromboembolism - mortality | Antibodies, Antiphospholipid - blood | Anticoagulants - administration & dosage | Humans | Middle Aged | Catastrophic Illness | Male | Antibodies, Anticardiolipin - blood | Antiphospholipid Syndrome - complications | Pregnancy Complications, Cardiovascular - immunology | Venous Thromboembolism - drug therapy | Incidence | Time Factors | Adult | Female | Retrospective Studies | Pregnancy Complications, Cardiovascular - mortality | Venous Thromboembolism - immunology | Antiphospholipid Syndrome - diagnosis | Risk Assessment | Administration, Oral | Antiphospholipid Syndrome - drug therapy | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Anticoagulants - adverse effects | Disease Progression | Venous Thromboembolism - etiology | Antiphospholipid Syndrome - immunology | Pregnancy | Pregnancy Complications, Cardiovascular - drug therapy | Italy | Aged | Hemorrhage - chemically induced | beta 2-Glycoprotein I - immunology | Pregnancy Complications, Cardiovascular - etiology | Viral antibodies | Cardiac patients | Antibodies | Lipids | Anticoagulants (Medicine) | Thromboembolism | Health aspects | Antiphospholipid syndrome
Journal Article
Journal Article
Blood, ISSN 0006-4971, 09/2018, Volume 132, Issue 13, pp. 1365 - 1371
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 4, pp. 303 - 312
This study shows that the mTORC pathway is central to the antiphospholipid syndrome. Among patients with kidney transplants and antiphospholipid syndrome, 70%... 
RAPAMYCIN | BETA-GLYCOPROTEIN-I | MEDICINE, GENERAL & INTERNAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | ANGIOPLASTY | ANTIBODY-MEDIATED REJECTION | POLYCYSTIC KIDNEY-DISEASE | SMOOTH-MUSCLE-CELLS | ANTI-BETA-GLYCOPROTEIN-I ANTIBODIES | SYNDROME NEPHROPATHY | VASCULOPATHY | Endothelium, Vascular - cytology | Cell Proliferation | Kidney - blood supply | Kidney - pathology | TOR Serine-Threonine Kinases - metabolism | Humans | Immunoglobulin G | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Antiphospholipid Syndrome - complications | TOR Serine-Threonine Kinases - antagonists & inhibitors | Autopsy | Adult | Female | Antiphospholipid Syndrome - metabolism | Immunosuppressive Agents - pharmacology | Kidney Diseases - metabolism | Sirolimus - therapeutic use | Antiphospholipid Syndrome - drug therapy | Kidney Transplantation | Sirolimus - pharmacology | Antibodies, Antiphospholipid - metabolism | Analysis of Variance | Endothelium, Vascular - metabolism | Endothelium, Vascular - pathology | Kidney Diseases - etiology | Metabolic Networks and Pathways - drug effects | Care and treatment | Rapamycin | Health aspects | Antiphospholipid syndrome | TOR protein | Cell proliferation | Lupus | Heart attacks | Kidneys | Transplants & implants | Sirolimus | AKT protein | Antiphospholipid antibodies | Kinases | Thrombosis | Endothelial cells | Endothelium | 1-Phosphatidylinositol 3-kinase | Vascular diseases | Nephropathy | Biopsy | Autoimmune diseases | Kidney transplantation
Journal Article